Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lubetzki

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Revue Neurologique|March 27, 2019
Impact of an adaptive program for cognitive and emotional deficits (ADACOG program) in multiple sclerosis patients with cognitive impairmentsF Pineau, J Socha, J-C Corvol, et al.
AIDS (London, England)|February 24, 2001
Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapyS Suarez, L Baril, B Stankoff, et al.
Life Sciences|November 15, 1982
Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the catM F Chesselet, A Cheramy, T D Reisine, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion moleculeP Charles, M P Hernandez, B Stankoff, et al.
Neurology|September 25, 1999
Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosisA Tourbah, J L Stievenart, O Gout, et al.
Neurology|April 13, 2005
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind studyB Stankoff, E Waubant, C Confavreux, et al.
Revue Neurologique|January 1, 1989
[Retrochiasmatic lesions in multiple sclerosis. Demonstration by visual evoked potentials. Correlation with magnetic resonance imaging]M H Rigolet, C Lubetzki, C Penet, et al.
Revue Neurologique|January 1, 1993
[Symptomatic heterozygotic adrenoleukodystrophy in adults. 10 cases]P Ménage, V Carreau, A Tourbah, et al.
Journal of Neurochemistry|February 1, 1986
Schwann cell marker defined by a monoclonal antibody (224-58) with species cross-reactivity. I. Cellular localizationA Guerci, M Monge, A Baron-Van Evercooren, et al.
Glia|September 1, 1996
Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin depositionS K Solly, J L Thomas, M Monge, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Revue Neurologique|March 27, 2019
Impact of an adaptive program for cognitive and emotional deficits (ADACOG program) in multiple sclerosis patients with cognitive impairmentsF Pineau, J Socha, J-C Corvol, et al.
AIDS (London, England)|February 24, 2001
Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapyS Suarez, L Baril, B Stankoff, et al.
Life Sciences|November 15, 1982
Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the catM F Chesselet, A Cheramy, T D Reisine, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion moleculeP Charles, M P Hernandez, B Stankoff, et al.
Neurology|September 25, 1999
Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosisA Tourbah, J L Stievenart, O Gout, et al.
Neurology|April 13, 2005
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind studyB Stankoff, E Waubant, C Confavreux, et al.
Revue Neurologique|January 1, 1989
[Retrochiasmatic lesions in multiple sclerosis. Demonstration by visual evoked potentials. Correlation with magnetic resonance imaging]M H Rigolet, C Lubetzki, C Penet, et al.
Revue Neurologique|January 1, 1993
[Symptomatic heterozygotic adrenoleukodystrophy in adults. 10 cases]P Ménage, V Carreau, A Tourbah, et al.
Journal of Neurochemistry|February 1, 1986
Schwann cell marker defined by a monoclonal antibody (224-58) with species cross-reactivity. I. Cellular localizationA Guerci, M Monge, A Baron-Van Evercooren, et al.
Glia|September 1, 1996
Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin depositionS K Solly, J L Thomas, M Monge, et al.
Pageof 10